
Collaboration - February 26, 2015
AstraZeneca, Orca Sign Pact
British biotech startup Orca got $122.5 million from AstraZeneca PLC after the two companies signed a three-year research agreement to develop Orca’s retinoic acid-related orphan nuclear receptor gamma inhibitors. Orca is slated to receive upfront and milestone payments from AstraZeneca, depending on the success of its RORϒ inhibitors in the program. There is potential for […]